Rapidly progressive glomerulonephritis

L P Erwig, Andrew Jackson Rees

Research output: Contribution to journalArticle

Abstract

The management of rapidly progressive glomerulonephritis has been transformed over the past thirty years. It has become one of the few forms of glomerulonephritis that can be effectively treated, and today overall renal survival is as high as 70%. Effective management of patients with RPGN requires prompt and accurate diagnosis so that patients are appropriately treated, and long term follow up to minimise the risk of relapse in patients with some types of those disease.

Original languageEnglish
Pages (from-to)S111-S119
Number of pages9
JournalJournal of Nephrology
Volume12
Publication statusPublished - 1999

Keywords

  • rapidly progressive glomerulonephritis
  • vasculitis
  • goodpastures disease
  • ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES
  • IDIOPATHIC CRESCENTIC GLOMERULONEPHRITIS
  • WEGENERS GRANULOMATOSIS
  • SYSTEMIC VASCULITIS
  • MONOCLONAL-ANTIBODY
  • GOODPASTURE ANTIGEN
  • ENDOTHELIAL-CELLS
  • DISEASE-ACTIVITY
  • NECROTIZING GLOMERULONEPHRITIS
  • EXPRESS PROTEINASE-3

Cite this

Erwig, L. P., & Rees, A. J. (1999). Rapidly progressive glomerulonephritis. Journal of Nephrology, 12, S111-S119.